1. Home
  2. TMDX vs UE Comparison

TMDX vs UE Comparison

Compare TMDX & UE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TMDX
  • UE
  • Stock Information
  • Founded
  • TMDX 1998
  • UE 2014
  • Country
  • TMDX United States
  • UE United States
  • Employees
  • TMDX N/A
  • UE N/A
  • Industry
  • TMDX Biotechnology: Electromedical & Electrotherapeutic Apparatus
  • UE Real Estate
  • Sector
  • TMDX Health Care
  • UE Finance
  • Exchange
  • TMDX Nasdaq
  • UE Nasdaq
  • Market Cap
  • TMDX 2.7B
  • UE 2.9B
  • IPO Year
  • TMDX 2019
  • UE N/A
  • Fundamental
  • Price
  • TMDX $62.72
  • UE $21.91
  • Analyst Decision
  • TMDX Buy
  • UE Hold
  • Analyst Count
  • TMDX 11
  • UE 2
  • Target Price
  • TMDX $116.10
  • UE $20.00
  • AVG Volume (30 Days)
  • TMDX 1.9M
  • UE 983.3K
  • Earning Date
  • TMDX 10-28-2024
  • UE 02-12-2025
  • Dividend Yield
  • TMDX N/A
  • UE 3.04%
  • EPS Growth
  • TMDX N/A
  • UE 533.18
  • EPS
  • TMDX 0.94
  • UE 2.20
  • Revenue
  • TMDX $401,090,000.00
  • UE $435,181,000.00
  • Revenue This Year
  • TMDX $82.52
  • UE N/A
  • Revenue Next Year
  • TMDX $25.91
  • UE $3.72
  • P/E Ratio
  • TMDX $70.11
  • UE $10.10
  • Revenue Growth
  • TMDX 109.09
  • UE 8.27
  • 52 Week Low
  • TMDX $60.80
  • UE $15.81
  • 52 Week High
  • TMDX $177.37
  • UE $23.85
  • Technical
  • Relative Strength Index (RSI)
  • TMDX 31.44
  • UE 46.30
  • Support Level
  • TMDX $60.80
  • UE $22.03
  • Resistance Level
  • TMDX $66.44
  • UE $22.84
  • Average True Range (ATR)
  • TMDX 4.10
  • UE 0.37
  • MACD
  • TMDX 0.50
  • UE -0.08
  • Stochastic Oscillator
  • TMDX 13.30
  • UE 27.96

About TMDX TransMedics Group Inc.

TransMedics Group Inc is a commercial-stage medical technology company transforming organ transplant therapy for end-stage organ failure patients across multiple disease states. It has developed the Organ Care System(OCS) to comprehensively address the limitations of cold storage. The OCS is a portable organ perfusion, optimization and monitoring system that utilizes technology to replicate near-physiologic conditions for donor organs outside of the human body. The Company has developed and is commercializing a proprietary system to preserve and deliver human organs for transplant in a near-physiologic condition to address the limitations of cold storage organ preservation.

About UE Urban Edge Properties of Beneficial Interest

Urban Edge Properties is a real estate investment trust principally focused on the management and development of retail real estate properties in urban communities in the U.S. Having originally been created to hold the majority of Vornado Realty Trust's shopping center businesses, Urban Edge's asset portfolio is mostly composed of shopping centers and malls in terms of total square footage. The company's holdings include necessity and convenience-oriented retailers, such as department stores, grocers, health clubs, and restaurants. Urban Edge's properties are mainly located in the New York City metropolitan region and within the DC to Boston corridor. The company generates nearly all of its revenue through the collection of rent from a large number of tenants.

Share on Social Networks: